ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.61
+2.01%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.21x
- Price / sales
- —
- Price / cash flow
- -4.38x
Enterprise value
- Enterprise value
- $81.4M
- EV / sales
- —
- EV / EBITDA
- -0.93x
- EV / EBIT
- -0.85x
- Market cap
- $420.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026